Literature DB >> 15546384

The role of type I interferons in non-viral infections.

Christian Bogdan1, Jochen Mattner, Ulrike Schleicher.   

Abstract

For a long time, the family of type I interferons (IFN-alpha/beta) has received little attention outside the fields of virology and tumor immunology. In recent years, IFN-alpha/beta regained the interest of immunologists, due to the phenotypic and functional characterization of IFN-alpha/beta-producing cells, the definition of novel immunomodulatory functions and signaling pathways of IFN-alpha/beta, and the observation that IFN-alpha/beta not only exerts antiviral effects but is also relevant for the pathogenesis or control of certain bacterial and protozoan infections. This review summarizes the current knowledge on the production and function of IFN-alpha/beta during non-viral infections in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15546384     DOI: 10.1111/j.0105-2896.2004.00207.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  57 in total

1.  Illuminating the role of type I IFNs in colitis.

Authors:  Stefan Wirtz; Markus F Neurath
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 2.  Should we inhibit type I interferons in sepsis?

Authors:  Tina Mahieu; Claude Libert
Journal:  Infect Immun       Date:  2006-09-25       Impact factor: 3.441

3.  Type I Interferons are essential for the efficacy of replicase-based DNA vaccines.

Authors:  Wolfgang W Leitner; Elke S Bergmann-Leitner; Leroy N Hwang; Nicholas P Restifo
Journal:  Vaccine       Date:  2006-05-06       Impact factor: 3.641

4.  Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T cells.

Authors:  Martin D Hyrcza; Colin Kovacs; Mona Loutfy; Roberta Halpenny; Lawrence Heisler; Stuart Yang; Olivia Wilkins; Mario Ostrowski; Sandy D Der
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

Review 5.  Innate immunity in the respiratory epithelium.

Authors:  Dane Parker; Alice Prince
Journal:  Am J Respir Cell Mol Biol       Date:  2011-02-17       Impact factor: 6.914

Review 6.  Harnessing cancer immunotherapy during the unexploited immediate perioperative period.

Authors:  Pini Matzner; Elad Sandbank; Elad Neeman; Oded Zmora; Vijaya Gottumukkala; Shamgar Ben-Eliyahu
Journal:  Nat Rev Clin Oncol       Date:  2020-02-17       Impact factor: 66.675

7.  Toll-like receptor 7 mediates early innate immune responses to malaria.

Authors:  Alyssa Baccarella; Mary F Fontana; Eunice C Chen; Charles C Kim
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

8.  Murine toll-like receptor 2 activation induces type I interferon responses from endolysosomal compartments.

Authors:  Nicole Dietrich; Stefan Lienenklaus; Siegfried Weiss; Nelson O Gekara
Journal:  PLoS One       Date:  2010-04-20       Impact factor: 3.240

9.  Bifidobacterium bifidum actively changes the gene expression profile induced by Lactobacillus acidophilus in murine dendritic cells.

Authors:  Gudrun Weiss; Simon Rasmussen; Lisbeth Nielsen Fink; Hanne Jarmer; Birgit Nøhr Nielsen; Hanne Frøkiaer
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

10.  Lymphadenopathy in a novel mouse model of Bartonella-induced cat scratch disease results from lymphocyte immigration and proliferation and is regulated by interferon-alpha/beta.

Authors:  Stefanie Kunz; Karin Oberle; Anna Sander; Christian Bogdan; Ulrike Schleicher
Journal:  Am J Pathol       Date:  2008-02-21       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.